Second Look provides CAD for mammography
Howtek has integrated a computer-aided detection (CAD) system called Second Look into its MultiRAD 850 film digitizer. Second Look, which is being provided by CADx Medical Systems, will offer radiologists a second opinion on the detection of breast
Howtek has integrated a computer-aided detection (CAD) system called Second Look into its MultiRAD 850 film digitizer. Second Look, which is being provided by CADx Medical Systems, will offer radiologists a second opinion on the detection of breast cancer, according to company officials.
CADx Medical Systems of Quebec develops and markets systems to be used with mammography and other imaging applications. The Second Look system, which is undergoing clinical trials in the U.S., is already being sold in Europe, Latin America, Canada, and Asia.
Howtek of Hudson, NH, designs, engineers, and manufactures digital image scanners, film digitizers, and related software for applications in medical imaging, graphic arts, and photography.
A patients mammography film is fed into the digitizer and Second Looks software analyzes it using proprietary algorithms. Second Look produces a printed paper image, called the Mammograph, which highlights potential areas of concern. After reviewing the mammogram, radiologists can use the Mammograph to assist with a diagnosis.
Second Look will be available in the U.S. when it gains FDA approval. CADx will file for FDA premarket clearance after clinical trials are complete at the end of the summer, said Bill Bussler, CADx spokesperson. Clinical trials are under way at 11 U.S. sites, including Johns Hopkins University and Beth Israel Deaconess Medical Center.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
